Curae and Piedmont Healthcare Announce Strategic Arrangement to Provide Non-Recourse Financing for Patients
Atlanticus Holdings Corporation (ATLC)
US:NASDAQ Investor Relations:
atlanticus.com/about
Company Research
Source: PR Web
Atlanta, GA (PRWEB) June 03, 2019 Curae™ is extremely proud to announce the successful implementation and launch of healthcare's first integrated non-recourse, patient-financing solution with Piedmont Healthcare. Curae™ lines of credit, provide financing to Piedmont Healthcare patients with all types of credit profiles. There is no impact to patients' credit scores to see whether they qualify for a Curae™ line of credit, which is an unsecured revolving line of credit. Curae™ lines of credit are issued by The Bank of Missouri, St. Robert, Mo.Curae Finance, LLC, is a subsidiary of Atlanticus Holdings Corporation, which has been in the consumer finance market more than 21 years servicing more than 17 million customers and supporting lenders who have originated over $25 billion in loans. Curae™ lines of credit are healthcare specific, patient-financing solutions for many types of healthcare providers including acute, surgical and elective disciplines. Curae™ lines of credit are available
Show less
Read more
Impact Snapshot
Event Time:
ATLC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATLC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATLC alerts
High impacting Atlanticus Holdings Corporation news events
Weekly update
A roundup of the hottest topics
ATLC
News
- Atlanticus Holdings Co. (NASDAQ: ATLC) had its price target raised by analysts at JMP Securities from $54.00 to $75.00. They now have a "market outperform" rating on the stock.MarketBeat
- Atlanticus Holdings Co. (NASDAQ: ATLC) had its price target raised by analysts at B. Riley from $50.00 to $70.00. They now have a "buy" rating on the stock.MarketBeat
- US Value Stocks Trading Below Estimated Worth In November 2024 [Yahoo! Finance]Yahoo! Finance
- Atlanticus Holdings Co. (NASDAQ: ATLC) had its price target raised by analysts at JMP Securities from $45.00 to $54.00. They now have a "market outperform" rating on the stock.MarketBeat
- Should Value Investors Buy Atlanticus (ATLC) Stock? [Yahoo! Finance]Yahoo! Finance
ATLC
Earnings
- 8/8/24 - Beat
ATLC
Sec Filings
- 12/20/24 - Form SCHEDULE
- 12/20/24 - Form 424B5
- 12/17/24 - Form 4
- ATLC's page on the SEC website